References Archive

Swiss Biotech Day 2017

The Swiss Biotech Day has long become the standard annual get-together of the Swiss bio­pharmaceutical industry. And Basel, as one of the most vivid cities in terms of biotechnological and pharmaceutical research, development and production, proved to be the ideal location.
20. November 2018/by l.eppler

10th Berlin Conference on IP in Life Sciences 2017

The 10th Berlin Conference on IP in Life Sciences took place on 24 February 2017 at the British Embassy in Berlin. The event was organized by BIOCOM AG.
16. November 2018/by l.eppler

Swiss Biotech Day 2016

The event “Swiss Biotech Day 2016” took place on 12 April 2016 in the Congress Center Basel. The event was organized by BIOCOM AG.
16. April 2016/by l.eppler

9th Berlin Conference on IP in Life Sciences 2016

Die Veranstaltung 9th Berlin Conference on IP in Life Sciences fand am 12. Februar 2016 in der französischen Botschaft in Berlin am Pariser Platz statt.
16. February 2016/by l.eppler

Panel Discussion Synthetic Biology 2015

The ,,Panel Discussion Synthetic Biology” was on 22 September 2015, at the Harnack-Haus in the Ihnenstraße 16-20 14195 Berlin. The event was organized by BIOCOM AG.
29. September 2015/by l.eppler

Panel Discussion Synthetic Biology 2015

Where is Synthetic Biology Developing in Germany? This was the topic of the BIOCOM event “Panel Discussion Synthetic Biology”, which took place on 22 September 2015 in the Harnack-Haus in Ihnestraße 16-20 14195 Berlin.
22. September 2015/by l.eppler

Swiss Biotech Day 2015

The Swiss Biotech Day is the leading biotechnology conference in Switzerland. This event has brought together more than 400 senior executives from the life science industry across Europe.
16. April 2015/by l.eppler

Life Science Day 2014

Life Science Day 2014 took place on October 16, 2014 in the Henry Ford Building of Freie Universität Berlin. The event was organized by BIOCOM AG.
16. October 2014/by l.eppler

Mid-term conference on bioeconomy 2014

With the “Mid-Term Conference on Bioeconomy” organised by the Federal Ministry of Education and Research on 5 June at ewerk in Berlin, the government took stock of the “National Research Strategy Bioeconomy 2030” launched at the end of 2010.
16. June 2014/by l.eppler

Swiss Biotech Day 2014

The Swiss Biotech Day on 8 April 2014 was the leading biotechnology conference in Switzerland. Every year, this event brings together more than 200 senior executives from the life science industry across Europe.
20. April 2014/by l.eppler

Focus on medium-sized companies: Personalised medicine

Paper, patents and patient files – the life sciences have made immense progress in recent years. At the same time, the amount of data to be handled is exploding. If you want to stay ahead, you need IT support.
20. March 2014/by l.eppler

7th Berlin Conference on IP in Life Sciences 2014

Zum siebten Mal fand die Veranstaltung ,,Berlin Conference on IP in Life Sciences” am 7. Februar 2014 in der Nordischen Botschaftenstatt. Organisiert wurde die Veranstaltung von BIOCOM AG. Thema diesmal: ,,Big Data – Big Drugs”
16. February 2014/by l.eppler

5th Berlin Conference on IP in Life Sciences 2012

Monoklonale Antikörper sind das am schnellsten wachsende Segment in der Biotech- und Pharmaindustrie. Heute sind vier der zehn meistverkauften Blockbuster Antikörper. Branchenprognosen gehen davon aus, dass der weltweite Umsatz mit Antikörpern im Jahr 2014 auf 58 Milliarden US-Dollar steigen wird. Pharma- und Biotech-Unternehmen investieren massiv in die Entwicklung neuer Antikörper zur Behandlung einer wachsenden Zahl von Krankheiten.
20. February 2012/by l.eppler

From greenhouse gas to feedstock: CO2 use – the biological perspective

Whether as a biofuel or as a building block for chemical products – there are already a number of approaches today to use the harmful greenhouse gas CO2 as a feedstock to build more complex carbon compounds. New perspectives of CO2 utilisation are the focus of the series of events “From greenhouse gas to feedstock”, which is carried out by BIOCOM in cooperation with the Deutsche Bundesstiftung Umwelt.
8. June 2011/by u.mommert

4th Berlin Conference on IP in Life Sciences 2011

Personalized Medicine – once seen as a threat to the Pharma Industry – is today viewed as a growth opportunity. In the future, the sale of pharmaceuticals must be redefined away from a bulk business as patients and treatments become individual and unique. Consequently, as the industry learns to deal with small populations, the development of orphan drugs becomes increasingly interesting.
20. February 2011/by l.eppler

3rd Berlin Conference on IP in Life Sciences 2010

Effective Life Cycle Management (LCM) is a critical factor for successful commercialisation of pharmaceutical R&D output. This conference offers a unique opportunity to gain insight in the portfolio planning strategies of pharmaceutical companies.
16. February 2010/by l.eppler

2nd Berlin Conference on IP in Life Sciences 2009

Biomarkers are used throughout the healthcare sector, from biological research laboratories to clinical patient monitoring. Biomarker diagnostics and drug therapy combinations form the basis for the next generation of effective and useful treatments for a broad spectrum of diseases.
16. February 2009/by l.eppler

1st Berlin Conference on IP in Life Sciences 2008

Die “1st Berlin Conference on IP in Life Sciences – Smart Clinical Trials” sollte tiefere Einblicke in die Gestaltung klinischer Studien im Hinblick auf die Verlängerung der IP-Lebensdauer durch pädiatrische Nutzungsdaten, die Durchführung von First-in-Man-Studien über Biologika, rechtliche Risiken und Haftungen geben.
16. February 2008/by l.eppler

What can we do for you?

Are you interested in our products or services? Please do not hesitate to contact us. We will be pleased to provide you with a quote – flexible and tailored directly to your needs. You can also call us at +49 (0)30 2649210.